| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $31.9M+40.3% | $22.7M+27.7% | $17.8M+150.8% | $7.1M |
| General and administrative | $7.8M+8.6% | $7.2M-0.9% | $7.3M-6.4% | $7.8M |
| Loss from operations | -$39.7M-32.7% | -$29.9M-19.3% | -$25.1M-63.0% | -$15.4M |
| Interest income | $3.4M+5.6% | $3.2M+174.9% | $1.2M+112.7% | $547K |
| Other income (expense) | $200K+14138.6% | -$1K+97.4% | -$56K | — |
| Net loss | -$36.1M-35.2% | -$26.7M-11.5% | -$24.0M-61.5% | -$14.8M |
| Net income (loss) per share - basic (in dollars per share) | -$0.38+17.4% | -$0.46+69.3% | -$1.50-61.3% | -$0.93 |
| Net income (loss) per share - diluted (in dollars per share) | -$0.38+17.4% | -$0.46+69.3% | -$1.50-61.3% | -$0.93 |
| Weighted average common shares outstanding - basic (in shares) | 95.2M+62.9% | 58.4M+265.9% | 16.0M+0.0% | 16.0M |
| Weighted average common shares outstanding - diluted (in shares) | 95.2M+62.9% | 58.4M+265.9% | 16.0M+0.0% | 16.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.